Preventing Alzheimer's With Cognitive Training

Recruiting Phase 3 Interventional Study
Age-related Cognitive Decline Alzheimer's Disease and Related Dementias
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Pivotal Trial This treatment is in the last trial phase before FDA approval. Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 and older
Sex
Any
Trial phase
Phase 3
Study type
Interventional
Purpose
Prevention
Participants needed
7,600 (estimated)
Sponsor
University of South Florida · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Dementia is the most expensive medical condition in the US and increases in prevalence with age. More than 5 million Americans have Alzheimer's disease, the most common form of dementia. Mild cognitive impairment is a transitional stage between normal cognitive aging and Alzheimer's disease or another type of dementia, and is indicative of higher risk for dementia. In addition to the obvious healt…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Be age 65 or older at time of consent * Have ability to speak and understand English or Spanish * Report adequate sensorimotor capacity to perform the computer exercises * Report adequate visual capacity to read from a computer screen at a typical viewing distance * Show adequ…
Contacts

Jennifer L O'Brien, PhD

727-873-4415

jenobrien@usf.edu

CONTACT

Jennifer Lister, PhD

813-974-9712

jlister@usf.edu

CONTACT